Molecular aspects of bladder cancer IV: gene therapy of bladder cancer

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Bladder cancer treatment remains challenging, with high recurrence and progression rates, particularly for superficial types.
• Advances in understanding cell function and genetics have linked diseases like bladder cancer to genetic material dysfunction.
• Gene therapy emerged as a potential direct treatment for genetically based diseases, with initial successes in 1990.

Purpose of the Study:

• To review general strategies and current state-of-the-art approaches in bladder cancer gene therapy.
• To highlight recent advancements in the field of gene therapy for bladder cancer.
• To provide an outlook on the future potential of gene therapy in managing bladder cancer.

Main Methods:

• Review of existing literature on gene therapy strategies for bladder cancer.
• Analysis of current research and clinical investigations.
• Synthesis of information on recent advances and future prospects.

Main Results:

• Gene therapy represents a significant area of research for bladder cancer.
• Various gene therapy strategies are under development to address treatment challenges.
• The field shows potential for reducing bladder cancer recurrence and progression.

Conclusions:

• Gene therapy holds promise as an additional treatment modality for bladder cancer.
• Continued research and development are expected to yield new therapeutic options.
• The future of bladder cancer treatment may be significantly impacted by gene therapy advancements.